Palvella Therapeutics Inc (PVLA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
27.87 -0.27 (-0.96%) 03/24/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 28.05 +0.18 (+0.65%) 16:12 ET
for Mon, Mar 24th, 2025
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Cash Flows From Operating Activities | |||||
Net Income | -26,754 | -17,647 | -22,799 | -14,059 | -9,850 |
Depreciation Amortization | 570 | 369 | 361 | 308 | 367 |
Income taxes - deferred | -164 | N/A | N/A | N/A | N/A |
Accounts receivable | 12,511 | -14,469 | -59 | N/A | 465 |
Accounts payable and accrued liabilities | 764 | -332 | 1,360 | -91 | 1,116 |
Other Working Capital | 21,893 | 63,537 | 6,096 | -791 | 593 |
Other Operating Activity | -9,886 | 18,296 | 653 | 1,927 | 2,243 |
Operating Cash Flow | $-1,066 | $49,754 | $-14,388 | $-12,706 | $-5,066 |
Cash Flows From Investing Activities | |||||
PPE Investments | -1,698 | -1,950 | -560 | -621 | -267 |
Purchase Of Investment | -117,582 | -43,925 | N/A | N/A | N/A |
Sale Of Investment | 110,405 | N/A | N/A | N/A | N/A |
Investing Cash Flow | $-8,875 | $-45,875 | $-560 | $-621 | $-267 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | N/A | N/A | N/A | 1,210 |
Debt Repayment | N/A | N/A | N/A | -1,158 | -182 |
Common Stock Issued | 48,511 | 4,090 | 15,221 | 25,774 | 11,963 |
Other Financing Activity | 0 | 0 | 0 | 0 | 7,342 |
Financing Cash Flow | $48,511 | $4,090 | $15,221 | $24,616 | $20,334 |
Exchange Rate Effect | -1,581 | 553 | -267 | -415 | -216 |
Beginning Cash Position | 37,878 | 29,356 | 29,350 | 18,474 | 3,689 |
End Cash Position | 74,867 | 37,878 | 29,356 | 29,349 | 18,474 |
Net Cash Flow | $36,989 | $8,522 | $6 | $10,875 | $14,785 |
Free Cash Flow | |||||
Operating Cash Flow | -1,066 | 49,754 | -14,388 | -12,706 | -5,066 |
Capital Expenditure | -1,698 | -1,950 | -560 | -621 | -267 |
Free Cash Flow | -2,764 | 47,804 | -14,948 | -13,326 | -5,333 |